PlainPharmaWatch

CMS Open Payments · Tool

Dendreon Pharmaceuticals LLC vs Merz Pharmaceuticals, LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Merz Pharmaceuticals, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 162, versus 150 for the other company. Its single largest recorded recipient represents 0.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Dendreon Pharmaceuticals LLC
HHI 150 · top recipient 0.1%
Ranked #1,626 of 1,838 companies by HHI
Merz Pharmaceuticals, LLC
HHI 162 · top recipient 0.1%
Ranked #1,612 of 1,838 companies by HHI

Payment Overview

Total Payments
$1.8M
% of Industry
0.0%
Transactions
10,474
Avg per Transaction
$170.92
Recipients
10,334
Avg per Recipient
$173.24
Payment Types
4
Top Payment Type
Food and Beverage
Total Payments
$1.8M
% of Industry
0.0%
Transactions
7,208
Avg per Transaction
$249.68
Recipients
7,100
Avg per Recipient
$253.48
Payment Types
8
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Dendreon Pharmaceuticals LLC vs Merz Pharmaceuticals, LLC - total reported payments in CMS Open Payments PY2024

Merz Pharmaceuticals, LLC$1.8MDendreon Pharmaceuticals LLC$1.8M

Payment Types Breakdown

Dendreon Pharmaceuticals LLC

Food and Beverage $353.5K

19.7%

Compensation for Services Other Than Consulting $282.9K

15.8%

Travel and Lodging $23.0K

1.3%

Education $469.00

0.0%

Merz Pharmaceuticals, LLC

Consulting Fee $216.0K

12.0%

Food and Beverage $209.3K

11.6%

Compensation for Services Other Than Consulting $141.9K

7.9%

Travel and Lodging $119.8K

6.7%

Grant $105.2K

5.8%

Space Rental or Facility Fees $71.8K

4.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Dendreon Pharmaceuticals LLC

  1. 1

    JUDD MOUL

    $45,862.75 · 28 txns

  2. 2

    JONATHAN HAMILTON

    $31,291.91 · 56 txns

  3. 3

    VINCENT BIVINS

    $29,344.83 · 18 txns

  4. 4

    VAHAN KASSABIAN

    $25,047.57 · 20 txns

  5. 5

    MAHDI TAHA

    $21,561.88 · 22 txns

Merz Pharmaceuticals, LLC

  1. 1

    GERARD FRANCISCO

    $61,373.02 · 45 txns

  2. 2

    TODD STITIK

    $42,191.95 · 56 txns

  3. 3

    MONICA VERDUZCO-GUTIERREZ

    $36,229.08 · 23 txns

  4. 4

    Vanderbilt University Medical Center

    $31,850.00 · 4 txns

  5. 5

    University Of Washington Med Ctr

    $24,879.60 · 2 txns

Summary Comparison

Metric Dendreon Pharmaceuticals LLC Merz Pharmaceuticals, LLC
Total Payments $1.8M $1.8M
% of Industry Total 0.0% 0.0%
Transaction Count 10,474 7,208
Avg per Transaction $170.92 $249.68
Recipient Count 10,334 7,100
Avg per Recipient $173.24 $253.48
Payment Type Count 4 8
Top Payment Type Food and Beverage Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.